These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 16586337)

  • 1. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
    Van Thuyne W; Delbeke FT
    Int J Sports Med; 2006 Sep; 27(9):745-50. PubMed ID: 16586337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of caffeine levels in urine in different sports in relation to doping control.
    Van Thuyne W; Roels K; Delbeke FT
    Int J Sports Med; 2005 Nov; 26(9):714-8. PubMed ID: 16237615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
    Kuipers H
    Int J Sports Med; 2007 Feb; 28(2):178; author reply 178. PubMed ID: 17290310
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of caffeine use in elite athletes following its removal from the World Anti-Doping Agency list of banned substances.
    Del Coso J; Muñoz G; Muñoz-Guerra J
    Appl Physiol Nutr Metab; 2011 Aug; 36(4):555-61. PubMed ID: 21854160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine consumption amongst British athletes following changes to the 2004 WADA prohibited list.
    Chester N; Wojek N
    Int J Sports Med; 2008 Jun; 29(6):524-8. PubMed ID: 18027309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of doping in Flanders in comparison to the prevalence of doping in international sports.
    Van Eenoo P; Delbeke FT
    Int J Sports Med; 2003 Nov; 24(8):565-70. PubMed ID: 14598191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine Caffeine Concentration in Doping Control Samples from 2004 to 2015.
    Aguilar-Navarro M; Muñoz G; Salinero JJ; Muñoz-Guerra J; Fernández-Álvarez M; Plata MDM; Del Coso J
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30699902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel analysis of stimulants in saliva and urine by gas chromatography/mass spectrometry: perspectives for "in competition" anti-doping analysis.
    Strano-Rossi S; Colamonici C; Botrè F
    Anal Chim Acta; 2008 Jan; 606(2):217-22. PubMed ID: 18082653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems of the use of pseudoephedrine by athletes.
    Pokrywka A; Tszyrsznic W; Kwiatkowska DJ
    Int J Sports Med; 2009 Aug; 30(8):569-72. PubMed ID: 19382058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Doping in sports].
    Jeschke J; Nekola J; Chlumský J
    Cas Lek Cesk; 1999 May; 138(10):291-7. PubMed ID: 10422337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declared use of medication in sports.
    Thuyne WV; Delbeke FT
    Clin J Sport Med; 2008 Mar; 18(2):143-7. PubMed ID: 18332689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
    Kolmonen M; Leinonen A; Pelander A; Ojanperä I
    Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of gas chromatography combined with simultaneously selected ion monitoring and full scan mass spectrometry in doping analysis.
    Van Thuyne W; Van Eenoo P; Delbeke FT
    J Chromatogr A; 2008 Nov; 1210(2):193-202. PubMed ID: 18849031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of caffeine in urine and saliva of horses subjected to urinary acidification.
    Carregaro AB; Mataqueiro MI; Soares OA; Queiroz-Neto A
    J Appl Toxicol; 2004; 24(6):513-8. PubMed ID: 15551384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Science and the rules governing anti-doping violations.
    Bowers LD
    Handb Exp Pharmacol; 2010; (195):513-31. PubMed ID: 20020378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone abuse in sports: the antidoping perspective.
    Barroso O; Mazzoni I; Rabin O
    Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
    Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. World anti-doping regulations for 2005: essential changes for athletes and physicians.
    Pabinger C; Gruber G
    Arch Orthop Trauma Surg; 2006 May; 126(4):286-8. PubMed ID: 16333634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.